Phoenix Financial’s Cellebrite CLBT Stock Holding History
Bought
Maintained
Sold
Other funds holding CLBT
TWCM
VC
PP
NTCM
CI
Phoenix Financial's CLBT Position: Q2 2026 in Review
Phoenix Financial increased its Cellebrite (CLBT) stake by 48% in Q2 2026, buying an estimated $26.4M and bringing the position to 6,181,269 shares worth $90.2M. The position accounts for 0.62% of the portfolio, ranked #44.
Phoenix Financial first reported a position in CLBT in Q4 2021 and has held it in 19 quarters since. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.
- Phoenix Financial held 6,181,269 shares of Cellebrite worth $90.2M as of Q2 2026.
- Phoenix Financial bought 2,000,000 Cellebrite shares in Q2 2026, an estimated $26.4M.
- Cellebrite made up 0.62% of Phoenix Financial's portfolio in Q2 2026, its #44 holding.
- Phoenix Financial first reported a position in Cellebrite in Q4 2021 and has held it in 19 quarters since.
- 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.
Based on Phoenix Financial's 13F filing for Q2 2026, filed 11 Aug 2026.